| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.057 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |